Nortriptyline
![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Aventyl, others |
Other names | Desitriptyline; ELF-101; E.L.F. 101; N-7048 |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682620 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | Tricyclic antidepressant (TCA) |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 32–79%[6] |
Protein binding | 92%[6] |
Metabolism | Liver |
Metabolites | 10-E-Hydroxynortriptyline |
Elimination half-life | 18–44 hours (mean 30 hours)[6] |
Excretion | Urine: 40%[6] Feces: minor[6] |
Identifiers | |
| |
JSmol) | |
SMILES
| |
| |
(verify) |
Nortriptyline, sold under the brand name Aventyl, among others, is a
Common side effects include dry mouth, constipation, blurry vision, sleepiness,
Nortriptyline was approved for medical use in the United States in 1964.
Medical uses
Nortriptyline is used to treat depression.[11] A level between 50 and 150 ng/mL of nortriptyline in the blood generally corresponds with an antidepressant effect.[12]
It is also used
Irritable bowel syndrome
Nortriptyline has also been used as an off-label treatment for irritable bowel syndrome (IBS).[17]
Contraindications
Nortriptyline should not be used in the acute recovery phase after myocardial infarction (heart attack).[5] Use of tricyclic antidepressants along with a monoamine oxidase inhibitor (MAOI), linezolid, or IV methylene blue are contraindicated as it can cause an increased risk of developing serotonin syndrome.[18]
Closer monitoring is required for those with a history of cardiovascular disease,
Side effects
The most common side effects include dry mouth, sedation, constipation, increased appetite, blurred vision and tinnitus.
Overdose
The symptoms and the treatment of an overdose are generally the same as for the other tricyclic antidepressants, including
Interactions
Excessive consumption of alcohol in combination with nortriptyline therapy may have a potentiating effect, which may lead to the danger of increased suicidal attempts or overdosage, especially in patients with histories of emotional disturbances or suicidal ideation.
It may interact with the following drugs:[22]
- heart rhythm medications such as flecainide (Tambocor), propafenone (Rhythmol), or quinidine (Cardioquin, Quinidex, Quinaglute)
- cimetidine
- guanethidine
- reserpine
Pharmacology
Nortriptyline is a strong norepinephrine reuptake inhibitor and a moderate serotonin reuptake inhibitor. Additionally, nortriptyline inhibits the activity of histamine and acetylcholine. Its pharmacologic profile is as the table shows with (inhibition or antagonism of all sites).[23][24]
Pharmacodynamics
Site | Ki (nM) | Species | Ref |
---|---|---|---|
SERT | 15–18 | Human | [25][26] |
NET | 1.8–4.4 | Human | [25][26] |
DAT | 1,140 | Human | [25] |
5-HT1A | 294 | Human | [27] |
5-HT2A | 5.0–41 | Human/rat | [28][27] |
5-HT2C | 8.5 | Rat | [28] |
5-HT3 | 1,400 | Rat | [29] |
5-HT6 | 148 | Rat | [30] |
α1 | 55 | Human | [27] |
α2 | 2,030 | Human | [27] |
β |
>10,000 | Rat | [31] |
D2 | 2,570 | Human | [27] |
H1 | 3.0–15 | Human | [32][27][33] |
H2 | 646 | Human | [32] |
H3 | 45,700 | Human | [32] |
H4 | 6,920 | Human | [32] |
mACh | 37 | Human | [27] |
M1 | 40 | Human | [34] |
M2 | 110 | Human | [34] |
M3 | 50 | Human | [34] |
M4 | 84 | Human | [34] |
M5 | 97 | Human | [34] |
σ1 | 2,000 | Guinea pig | [35] |
Values are Ki (nM). The smaller the value, the more strongly the drug binds to the site. |
Nortriptyline is an active metabolite of
Nortriptyline may also have a sleep-improving effect due to antagonism of the H1 and 5-HT2A receptors.[37] In the short term, however, nortriptyline may disturb sleep due to its activating effect.
In one study, nortriptyline had the highest affinity for the dopamine transporter among the tricyclic antidepressants (KD = 1,140 nM) besides amineptine (a norepinephrine–dopamine reuptake inhibitor), although its affinity for this transporter was still 261- and 63-fold lower than for the norepinephrine and serotonin transporters (KD = 4.37 and 18 nM, respectively).[25]
Pharmacogenetics
Nortriptyline is metabolized in the liver by the hepatic enzyme CYP2D6, and genetic variations within the gene coding for this enzyme can affect its metabolism, leading to changes in the concentrations of the drug in the body.[38] Increased concentrations of nortriptyline may increase the risk for side effects, including anticholinergic and nervous system adverse effects, while decreased concentrations may reduce the drug's efficacy.[39][40][41]
Individuals can be categorized into different types of CYP2D6 metabolizers depending on which genetic variations they carry. These metabolizer types include poor, intermediate, extensive, and ultrarapid metabolizers. Most individuals (about 77–92%) are extensive metabolizers,[41] and have "normal" metabolism of nortriptyline. Poor and intermediate metabolizers have reduced metabolism of the drug as compared to extensive metabolizers; patients with these metabolizer types may have an increased probability of experiencing side effects. Ultrarapid metabolizers use nortriptyline much faster than extensive metabolizers; patients with this metabolizer type may have a greater chance of experiencing pharmacological failure.[39][40][41]
The Clinical Pharmacogenetics Implementation Consortium recommends avoiding nortriptyline in persons who are CYP2D6 ultrarapid or poor metabolizers, due to the risk of a lack of efficacy and side effects, respectively. A reduction in starting dose is recommended for patients who are CYP2D6 intermediate metabolizers. If use of nortriptyline is warranted, therapeutic drug monitoring is recommended to guide dose adjustments.[41] The Dutch Pharmacogenetics Working Group recommends reducing the dose of nortriptyline in CYP2D6 poor or intermediate metabolizers, and selecting an alternative drug or increasing the dose in ultrarapid metabolizers.[42]
Chemistry
Nortriptyline is a
History
Nortriptyline was developed by Geigy.[52] It first appeared in the literature in 1962 and was patented the same year.[52] The drug was first introduced for the treatment of depression in 1963.[52][53]
Society and culture
Generic names
Nortriptyline is the
Brand names
Brand names of nortriptyline include Allegron, Aventyl, Noritren, Norpress, Nortrilen, Norventyl, Norzepine, Pamelor, and Sensival, among many others.[49][50][55]
Research
Although not approved by the US Food and Drug Administration (FDA) for neuropathic pain, randomized controlled trials have demonstrated the effectiveness of tricyclic antidepressants for the treatment of this condition in both depressed and non-depressed individuals. In 2010, an evidence-based guideline sponsored by the International Association for the Study of Pain recommended nortriptyline as a first-line medication for neuropathic pain.[56] However, in a 2015 Cochrane systematic review the authors did not recommend nortriptyline as a first-line agent for neuropathic pain.[57][58]
It may be effective in the treatment of tobacco-cessation.[59][60]
References
- ^ "Nortriptyline Use During Pregnancy". Drugs.com. 22 June 2020. Retrieved 10 October 2020.
- ^ Anvisa (31 March 2023). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 16 August 2023.
- ^ "Product monograph brand safety updates". Health Canada. February 2024. Retrieved 24 March 2024.
- ^ "Aventyl Product information". Health Canada. 10 January 2022. Retrieved 26 October 2024.
- ^ a b "Pamelor- nortriptyline hydrochloride capsule". DailyMed. 9 May 2024. Retrieved 26 October 2024.
- ^ ISBN 978-1-60913-345-0.
- ^ ISBN 9780857113382.
- ^ a b c d e f g h i "Nortriptyline Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 22 March 2019.
- ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
- ^ "Nortriptyline Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
- ^ a b "Nortriptyline". MedlinePlus. National Library of Medicine. Retrieved 6 May 2019.
- PMID 2683251.
- ISBN 0-85369-499-0.
- PMID 8444763.
- PMID 11052409.
- PMID 15064003.
- ^ "The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders" (PDF).
- PMID 29489270. Retrieved 3 October 2018.
- PMID 23425522.
- ^ a b Brayfield A, ed. (9 January 2017). "Nortriptyline Hydrochloride – Martindale: The Complete Drug Reference". MedicinesComplete. Pharmaceutical Press. Retrieved 11 August 2017.
- ^ "ALLEGRON". TGA eBusiness Services. Arrow Pharma Pty Ltd. 13 October 2016. Retrieved 11 August 2017.
- ^ "nortriptyline". Cardiosmart. Retrieved 3 October 2018.[failed verification]
- ^ a b Roth BL, Driscol J. "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 14 August 2017.
- ^ Brunton L, Chabner B, Knollman B. Goodman and Gilman's The Pharmacological Basis of Therapeutics, Twelfth Edition. McGraw Hill Professional; 2010.
- ^ PMID 9537821.
- ^ PMID 9400006.
- ^ S2CID 21236268.
- ^ S2CID 24889381.
- PMID 2533080.
- PMID 7680751.
- PMID 8699.
- ^ S2CID 14274150.
- PMID 16782354.
- ^ PMID 8100134.
- PMID 2877462.
- PMID 20722174.
- PMID 16889107.
- S2CID 7940406.
- ^ S2CID 20888081.
- ^ PMID 17113714.
- ^ PMID 23486447.
- S2CID 2475005.
- ^ ISBN 978-94-007-5805-6.
- ISBN 978-0-7817-6879-5.
- ISBN 978-0-471-95052-3.
- ISBN 978-3-527-64632-6.
- ISBN 1-56053-470-2.
- ISBN 978-0-19-162675-3.
- ^ ISBN 978-1-4757-2085-3.
- ^ ISBN 978-3-88763-075-1.
- ^ "ChemIDplus - 62265-06-9 - AMLRZIZSGSCSHZ-UHFFFAOYSA-N - Desipramine dibudinate - Similar structures search, synonyms, formulas, resource links, and other chemical information".
- ^ PMID 19557250.
- ISBN 978-0-7817-2845-4.
- ^ ISBN 978-94-011-4439-1.
- ^ a b c "Nortriptyline".
- PMID 20194146.
- PMID 25569864.
- PMID 39004954.
- PMID 36938244.
- PMID 37230961.